Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Michael Dorfman, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by David Dorfman and Elizabeth Morgan.
Connection Strength

0.748
  1. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation. Hum Pathol. 2017 07; 65:166-174.
    View in: PubMed
    Score: 0.178
  2. Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma. Am J Surg Pathol. 2014 Nov; 38(11):1557-70.
    View in: PubMed
    Score: 0.149
  3. An improved algorithm for activated protein C resistance and factor V Leiden screening. Am J Clin Pathol. 2013 Sep; 140(3):379-86.
    View in: PubMed
    Score: 0.137
  4. Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma. Leuk Lymphoma. 2012 Oct; 53(10):1905-10.
    View in: PubMed
    Score: 0.125
  5. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018 05 22; 9(1):2024.
    View in: PubMed
    Score: 0.048
  6. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586.
    View in: PubMed
    Score: 0.041
  7. Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol. 2014 Jun; 38(6):768-75.
    View in: PubMed
    Score: 0.036
  8. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One. 2013; 8(6):e67306.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.